Combination of two target agonists of the thrombopoietin and thrombopoietin receptor in the treatment of elderly patients with refractory immune thrombocytopenia
Author(s) -
Jundong Zhang,
Zining Wang,
Hao Chen,
Xuechun Lu
Publication year - 2022
Publication title -
cancer pathogenesis and therapy
Language(s) - English
Resource type - Journals
ISSN - 2949-7132
DOI - 10.1016/j.cpt.2022.09.005
Subject(s) - thrombopoietin , thrombopoietin receptor , eltrombopag , agonist , platelet , medicine , adverse effect , refractory (planetary science) , pharmacology , receptor , immune thrombocytopenia , romiplostim , immunology , haematopoiesis , biology , microbiology and biotechnology , stem cell , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom